Making clinical trials more relevant: improving and validating the PRECIS tool for matching trial design decisions to trial purpose.
about
A Framework for Enhancing the Value of Research for Dissemination and ImplementationThe challenge of comorbidity in clinical trials for multiple sclerosisDifferences between the real and the desired worlds in the results of clinical trialsStakeholders' views on the ethical challenges of pragmatic trials investigating pharmaceutical drugs.How pragmatic is it? Lessons learned using PRECIS and RE-AIM for determining pragmatic characteristics of researchUse of PRECIS ratings in the National Institutes of Health (NIH) Health Care Systems Research Collaboratory.Efficacy and effectiveness trials have different goals, use different tools, and generate different messages.Exploring the pragmatic and explanatory study design on outcomes of systematic reviews of public health interventions: a case study on obesity prevention trials.A large cluster randomized trial of outcome-based pathways to improve home-based wound care.Effectiveness of centre-based childcare interventions in increasing child physical activity: a systematic review and meta-analysis for policymakers and practitioners.GetReal: from efficacy in clinical trials to relative effectiveness in the real world.Rating of Included Trials on the Efficacy-Effectiveness Spectrum: development of a new tool for systematic reviews.Inter-rater Reliability Assessment of ASPECT-R: (A Study Pragmatic-Explanatory Characterization Tool-Rating).The feasibility and RE-AIM evaluation of the TAME health pilot study.Comparative effectiveness trials in asthma - how will I recognize one?A comparison of meta-analytic methods for synthesizing evidence from explanatory and pragmatic trials.Qualitative approaches to use of the RE-AIM framework: rationale and methods.Understanding practice-based research participation: The differing motivations of engaged vs. non-engaged clinicians in pragmatic clinical trials.
P2860
Q24282580-3EA61356-045C-4392-8D5C-F7990B8DE528Q26765031-3BCDE91C-FA93-4A46-A5F9-269A0F716081Q26786579-064EFAC1-7414-4D76-8D84-90FA4508C705Q27332116-9EC27CF5-4D47-4247-B74C-BCD06FAC359BQ34571250-3EF8B4B9-A3AC-4A46-BAC0-6E7D54A1DA10Q36469158-AC4642F7-BB56-48A4-9E60-4C58446B20AEQ37300935-2F2C8282-B6F4-4113-B329-D1223AC4E713Q38191498-0676FA4E-7652-4F1E-AB20-DEA5EF38CABEQ38603347-CC30D946-B9BB-4494-80FB-975C04196F22Q38785722-DD45D757-61B0-42B0-AC28-ECC9A2A665ACQ38889823-9FDE94CE-F149-44BC-B3FC-A2EDCF477272Q38966154-17D52C8D-23AA-4D03-B24B-B411BD7E0496Q39646616-575FD6DA-8D97-4A6A-9CF4-EDAF7720A979Q41396409-458A6180-753A-42C2-9BF5-88AF54C63365Q46958080-99D28ABF-52F0-4AB6-AAC6-67000E467FBEQ47839541-4678D3A4-77A8-4BF1-9333-61A34CA0246AQ52357137-3EEA38C0-EA53-4AA3-ABB0-B7AE3F26AE90Q55312450-B610D0A0-272E-482A-821F-CC04F07E5167
P2860
Making clinical trials more relevant: improving and validating the PRECIS tool for matching trial design decisions to trial purpose.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 27 April 2013
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Making clinical trials more re ...... gn decisions to trial purpose.
@en
Making clinical trials more re ...... gn decisions to trial purpose.
@nl
type
label
Making clinical trials more re ...... gn decisions to trial purpose.
@en
Making clinical trials more re ...... gn decisions to trial purpose.
@nl
prefLabel
Making clinical trials more re ...... gn decisions to trial purpose.
@en
Making clinical trials more re ...... gn decisions to trial purpose.
@nl
P2860
P50
P356
P1433
P1476
Making clinical trials more re ...... gn decisions to trial purpose.
@en
P2093
Frank Sullivan
Peter Donnan
P2860
P2888
P356
10.1186/1745-6215-14-115
P577
2013-04-27T00:00:00Z
P5875
P6179
1001730041